Acta Med. 2024, 67: 64-68

https://doi.org/10.14712/18059694.2024.22

VIPoma: An Unusual Cause of Chronic Diarrhea

Sutharin Suteetorna,b, Krit Kitisinc, Natcha Wanpiyaratd, Supaksorn Kunjane, Thiti Snabboona,f

aDepartment of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
bDepartment of Medicine, Queen Savang Vadhana Memorial Hospital, Chonburi province, Thailand
cDepartment of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
dDepartment of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
eCenter for Medical Diagnostic Laboratories, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
fExcellence Center in Diabetes, Hormone and Metabolism, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand

Received June 3, 2024
Accepted August 24, 2024

References

1. Arasaradnam RP, Brown S, Forbes A, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut. 2018; 67(8): 1380–99. <https://doi.org/10.1136/gutjnl-2017-315909> <PubMed>
2. Anderson CW, Bennett JJ. Clinical Presentation and Diagnosis of Pancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am. 2016; 25(2): 363–74. <https://doi.org/10.1016/j.soc.2015.12.003>
3. Jensen RT, Cadiot G, Brandi ML, et al. Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012; 95(2): 98–119. <https://doi.org/10.1159/000335591> <PubMed>
4. Belei OA, Heredea ER, Boeriu E, et al. Verner-Morrison syndrome. Literature review. Rom J Morphol Embryol. 2017; 58(2): 371–6.
5. Schizas D, Mastoraki A, Bagias G, et al. Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review. J BUON. 2019; 24(2): 415–23.
6. Chen C, Zheng Z, Li B, et al. Pancreatic VIPomas from China: Case reports and literature review. Pancreatology. 2019; 19(1): 44–9. <https://doi.org/10.1016/j.pan.2018.10.007>
7. Yao JC, Eisner MP, Leary C, et al. Population based study of islet cell carcinoma. Ann Surg Oncol. 2007; 14(12): 3492–500. <https://doi.org/10.1245/s10434-007-9566-6> <PubMed>
8. Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ. Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg. 2008; 12(2): 382–93. <https://doi.org/10.1007/s11605-007-0177-0>
9. De Herder WW. Biochemistry of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab. 2007; 21(1): 33–41. <https://doi.org/10.1016/j.beem.2006.12.002>
10. Pavel M, Öberg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31(7): 844–60. <https://doi.org/10.1016/j.annonc.2020.03.304>
11. Azizian A, König A, Ghadimi M. Treatment options of metastatic and nonmetastatic VIPoma: a review. Langenbecks Arch Surg. 2022; 407(7): 2629–36. <https://doi.org/10.1007/s00423-022-02620-7> <PubMed>
12. Halfdanarson TR, Strosberg JR, Tang L, et al. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors. Pancreas. 2020; 49(7): 863–81. <https://doi.org/10.1097/MPA.0000000000001597>
13. Smith SL, Branton SA, Avino AJ, et al. Vasoactive intestinal poly­peptide secreting islet cell tumors: a 15-year experience and review of the literature. Surgery. 1998; 124(6): 1050–5. <https://doi.org/10.1067/msy.1998.92005>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive